Anti-desmoglein-2 autoantibodies do not discriminate between UK boxer dogs with and without arrhythmogenic right ventricular cardiomyopathy
Vet Rec. 2025 Dec 6. doi: 10.1002/vetr.6014. Online ahead of print.ABSTRACTBACKGROUND: Evidence regarding the diagnostic utility of serum anti-desmoglein-2 (DSG2) autoantibodies for arrhythmogenic right ventricular cardiomyopathy (ARVC) in boxer dogs is conflicting.METHODS: Prospective standardised

